Login
Please select your location and reference genome:

Latest News and Blogs

Charles’ Story

Charles’ Story

Our daughter Imogen was born in 2012 at 30 weeks, and spent her first month in intensive care.

The complexity of epilepsy - an overview

The complexity of epilepsy - an overview

My name is Charles, and I'm both a Genome Scientist and the Patient Advocacy & Engagement Lead at Congenica, Cambridge, UK

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion.

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General.

Inherited Disorders: Bioinformatic Analysis that Surpasses All Others

Inherited Disorders: Bioinformatic Analysis that Surpasses All Others

A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations

Our plans for the future: a video message from our CEO and Chairman

Our plans for the future: a video message from our CEO and Chairman

Congenica CEO David Atkins PhD is joined by Chairman Andy Richards OBE in announcing the company's Series C fundraise.

The culture changes needed to mainstream genomics

The culture changes needed to mainstream genomics

We spoke to a number of industry leaders to discuss their thoughts on the culture changes needed to mainstream genomics.

The importance of improving the efficiency of genetic analysis

The importance of improving the efficiency of genetic analysis

We spoke to a number of industry leaders to find out their thoughts on the importance of improving the efficiency of genetic analysis.

The benefits and challenges of mainstreaming genomics and precision medicine

The benefits and challenges of mainstreaming genomics and precision medicine

We spoke to a number of industry leaders to discuss their thoughts on the benefits and challenges of mainstreaming genomics and precision medicine

Genome UK: the future of healthcare

Genome UK: the future of healthcare

Congenica's response to the UK Government's national genomic healthcare strategy, setting out its vision to extend the UK’s leadership in genomics

The future of genotype-phenotype data standards to improve outcomes

The future of genotype-phenotype data standards to improve outcomes

Supporting Rare Disease Clinical Genomics: The future of genotype phenotype data standards & sharing for analysis to improve medical outcomes